tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Haleon PLC Executes Share Buyback Transaction

Story Highlights
  • Haleon PLC purchased 2.9 million shares for cancellation on September 2, 2025.
  • This transaction reduces Haleon’s voting shares to 8.95 billion, affecting shareholder notifications.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Haleon PLC Executes Share Buyback Transaction

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Haleon PLC Sponsored ADR ( (HLN) ) just unveiled an update.

On September 2, 2025, Haleon PLC executed a transaction involving the purchase and cancellation of 2,900,000 ordinary shares as part of the second tranche of its share buyback program announced in July 2025. This move is likely to impact the company’s share capital structure, reducing the number of shares with voting rights to 8,952,441,206, which may influence shareholder notifications under FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (HLN) stock is a Hold with a $10.50 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.

Spark’s Take on HLN Stock

According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.

Haleon PLC’s overall stock score reflects a strong financial position and operational improvements, particularly in international markets. However, challenges in North America and stagnant revenue growth weigh on the score. Technical indicators and valuation suggest moderate potential for growth, with no significant corporate events impacting the assessment.

To see Spark’s full report on HLN stock, click here.

More about Haleon PLC Sponsored ADR

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health through its diverse product portfolio. The company operates in six major categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, which are built on a foundation of trusted science, innovation, and deep human understanding.

Average Trading Volume: 11,614,228

Technical Sentiment Signal: Buy

Current Market Cap: $43.18B

For detailed information about HLN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1